NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma
Clinical Cancer Research2016Vol. 22(12), pp. 3105–3117
Citations Over TimeTop 12% of 2016 papers
Robin Kit‐Ho Lai, Mingjing Xu, David Kung‐Chun Chiu, Aki Pui‐Wah Tse, Larry Lai Wei, Cheuk‐Ting Law, Derek Lee, Chun‐Ming Wong, Maria Pik Wong, Irene Oi‐Lin Ng, Carmen Chak‐Lui Wong
Abstract
Our study has provided the first clinical relevance of NDUFA4L2 in human cancer and suggested that HCC patients with NDUFA4L2 overexpression may be suitable candidates for HIF inhibitor treatment. Clin Cancer Res; 22(12); 3105-17. ©2016 AACR.
Related Papers
- → The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities(2014)416 cited
- → Characterization of tumor hypoxia by 31P MR spectroscopy.(1991)28 cited
- → HCC-Mark: a simple non-invasive model based on routine parameters for predicting hepatitis C virus related hepatocellular carcinoma(2020)3 cited
- → Improving prognosis of patients with very early hepatocellular carcinoma: How far are we going?(2020)1 cited
- → Hypoxia-induced tumor biological behavior changes and application of radiotracers for PET imaging of tumor hypoxia(2017)